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To the Editor:
Gene frequencies at a locus in a randomly interbreeding
diploid population and population genotype frequencies
remain constant from generation to generation, if mating
is random and mutation, selection, and migration do not
occur (Stern, 1943). The Hardy–Weinberg law (Hardy, 1908;
Weinberg, 1908) states that should the genotype frequen-
cies be perturbed for any reason, they will come to the
expected equilibrium frequencies after one generation of
random mating.
Population-genetic studies investigating genetic poly-
morphisms of Mendelian inheritance should always test the
presence of the Hardy–Weinberg criteria. According to our
experience however, data about HWE calculations are not
always presented in articles. In this retrospective survey, we
tested whether this law was checked in papers published in
the Journal of Investigative Dermatology since 1998.
The number of publications about genetic polymorph-
isms between January 1998 and May 2003 in the Journal of
Investigative Dermatology was 76. Of these, those articles
(n¼ 22) that fulfilled the following criteria were selected:
investigation of biallelic genetic polymorphism with Mende-
lian inheritance; use of healthy reference population at the
study; and availability of genotype distribution data. We re-
calculated HWE in each available genotype using the
Arlequin software (http://anthropologie.unige.ch/arlequin/).
The level of statistical significance was set at po0.05.
Only eight of the selected 22 (36%) publications
performed HWE calculations. HWE error occurred in nine
papers and remained unreported in each case. In each
case, we analyzed how the lack of HW criteria affects the
interpretation of results (see Table I).
Gonzalez et al (2000) checked the presence of OTF3 gene
polymorphisms and mutations of the MHC and other HLA
genes in psoriasis. HW criteria were not fulfilled in the case of
MHC S393 polymorphism in healthy reference subjects;
therefore, the significance of this genetic polymorphism in
psoriasis cannot be evaluated in this study. On the other
hand, the MHC S394 polymorphism did not fulfill HW criteria
in the diseased population, and this may suggest a possible
association between the MHC S394 allele and psoriasis.
Mee and Cork (1998) found no correlation between VDR
genotype and clinical responsiveness to calcipotriol; how-
ever, patients’ genotype altogether missed HWE, suggest-
ing a possible correlation between VDR BsmI and psoriasis.
This theory is in line with the observed correlation between
VDR BsmI and psoriasis in Japanese patients (Saeki et al,
2002). The calculated HW disequilibrium in the study would
further strengthen the presence of the association between
this genotype and psoriasis.
Pyo et al (2003) found that the TAP and HLA-DM alleles
could lead to genetic susceptibility toward psoriasis in
Koreans. They calculated HWE, but not for each gene. The ex-
ception was TAP2, as, according to their report, they could
not discriminate heterozygotes by their typing system.
Indeed, the TAP2-665 polymorphism misses the HWE in
their population and this questions the conclusions drawn
from their TAP2-665 results.
According to the finding of Richter-Hintz et al (2003)
‘‘variant alleles coding for phase II enzymes only GST M1,
but not GST T1 or NQOR, correlated with a risk to contract
psoriasis. Interestingly, heterozygosity for CYP2C19 alleles
n1A and n2A was associated with increased risk for ‘‘late
onset’’ psoriasis, whereas this genotype was protective for
psoriatic arthritis.’’ Although according to their report
genotype distribution fulfilled HWE, NQOR and the GST
M1 polymorphisms missed HWE in their reference popula-
tion, and this questions their conclusions.
McGregor et al (2002) inferred functional differences
between polymorphic forms of p53 that are likely to be
relevant to skin carcinogenesis. The p53–72 genotype
misses HWE in their study in healthy individuals with skin
type V. Therefore, this finding should be treated cautiously
for individuals with this skin type and should be further
tested using another cohort of healthy reference subjects.
Another skin cancer study (Kennedy et al, 2002) detected
no associations between MICA gene polymorphism and
increased risk for skin cancer. The MICA 5.1 polymorphism
missed the HWE in reference subjects, in basal cell carci-
noma patients, and also in malignant melanoma patients.
Cairey-Remonnay et al (2002) found no correlation with
human papillomavirus status in the TP53 polymorphism of
exon 4 at codon 72 in cutaneous squamous cell carcinoma
and immunocompetent individuals. The TP53 polymorphism
of exon 4 at codon 72 misses, however, HWE in immunoco-
mpetent blood samples and, therefore, their finding (i.e., the
TP53 polymorphism could present a potential risk factor for
squamous cell carcinoma in renal transplant recipients)
needs further support.
Werth et al (2002a) extensively investigated the genomics
of dermatomyositis. In their first work, they concluded thatAbbreviation: HWE, Hardy–Weinberg equilibrium
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the tumor necrosis factor 308A polymorphism is asso-
ciated with dermatomyositis. The lack of HWE, however,
occurred in the combination of TNF-308A and HLA DR3.
Therefore, the association of TNF-308A and HLA DR3 is
further supported by this finding.
In the second publication (Werth et al, 2002b), the
polymorphism of MBL Asp54 fulfilled HWE criteria neither
in the control group nor in Caucasian DLE cases. As the
control group missed HWE, the overrepresentation of this
polymorphism in patients needs further investigations.
If the control population misses the HWE, the results
should be treated cautiously because the observed geno-
type distribution in the reference population does not
represent the genotype distribution in healthy people and,
therefore, conclusions are of limited value. If HWE criteria
are fulfilled in the healthy reference group, but not in the
diseased population, this may be a further evidence for the
existence of the association between disease and poly-
morphism (for statistical details, see Deng et al, 2001; Hoh
et al, 2001).
There are several explanations as to why the observed
genotype frequency deviates significantly from the ex-
pected one. One or more of the assumptions of the model
may be incorrect, non-random mating or gene flow
occurred between the sampled and another population, or
selection has operated. If the HW law is not fulfilled, there
might also be a sampling error (Hedrick, 1983).
In conclusion, in line with the recommendation of Tiret and
Cambien (1995), we suggest that providing genotype
distribution data along with the results of performed HWE
calculations should be a must when the results of population-
based genetic studies are published.
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